GENEVA, April 1 -- RAQUALIA PHARMA INC. (1-21-19 Meieki Minami, Nakamura-ku, Nagoya-shi, Aichi4500003) filed a patent application (PCT/JP2024/033474) for "AZASPIRO DERIVATIVE SALT" on Sep 19, 2024. With publication no. WO/2025/063240, the details related to the patent application was published on Mar 27, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): NUMATA Toyoharu (c/o RaQualia Pharma Inc., 1-21-19 Meieki Minami, Nakamura-ku, Nagoya-shi, Aichi4500003), MATSUOKA Yoko (c/o RaQualia Pharma Inc., 1-21-19 Meieki Minami, Nakamura-ku, Nagoya-shi, Aichi4500003), MATSUSHITA Aya (c/o RaQualia Pharm...